Binding Sites for Bilobalide, Diltiazem, Ginkgolide, and Picrotoxinin at the 5-HT3 Receptor
- 19 April 2011
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 80 (1), 183-190
- https://doi.org/10.1124/mol.111.071415
Abstract
Bilobalide (BB), ginkgolide B (GB), diltiazem (DTZ), and picrotoxinin (PXN) are 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists in which the principal sites of action are in the channel. To probe their exact binding locations, 5-HT3 receptors with substitutions in their pore lining residues were constructed (N−4′Q, E−1′D, S2′A, T6′S, L7′T, L9′V, S12′A, I16′V, D20′E), expressed in Xenopus laevis oocytes, and the effects of the compounds on 5-HT-induced currents were examined. EC50 values at mutant receptors were less than 6-fold different from those of wild type, indicating that the mutations were well tolerated. BB, GB, DTZ, and PXN had pIC50 values of 3.33, 3.14, 4.67, and 4.97, respectively. Inhibition by BB and GB was abolished in mutant receptors containing T6′S and S12′A substitutions, but their potencies were enhanced (42- and 125-fold, respectively) in S2′A mutant receptors. S2′A substitution also caused GB ligand trap. PXN potency was modestly enhanced (5-fold) in S2′A, abolished in T6′S, and reduced in L9′V (40-fold) and S12′A (7-fold) receptors. DTZ potency was reduced in L7′T and S12′A receptors (5-fold), and DTZ also displaced [3H]granisetron binding, indicating mixed competitive/noncompetitive inhibition. We conclude that regions close to the hydrophobic gate of M2 are important for the inhibitory effects of BB, GB, DTZ, and PXN at the 5-HT3 receptor; for BB, GB, and PXN, the data show that the 6′ channel lining residue is their major site of action, with minor roles for 2′, 9′, and 12′ residues, whereas for DTZ, the 7′ and 12′ sites are important.This publication has 54 references indexed in Scilit:
- Ginkgolide B and bilobalide block the pore of the 5-HT3 receptor at a location that overlaps the picrotoxin binding siteNeuropharmacology, 2011
- Agonists and Antagonists Bind to an A-A Interface in the Heteromeric 5-HT3AB ReceptorBiophysical Journal, 2010
- Stoichiometric Pore Mutations of the GABAAR Reveal a Pattern of Hydrogen Bonding with PicrotoxinBiophysical Journal, 2008
- Stoichiometric analysis of the TM2 6′ phenylalanine mutation on desensitization in α1β2 and α1β2γ2 GABAA receptorsNeuroscience Letters, 2008
- The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5‐HT3 receptorsBritish Journal of Pharmacology, 2007
- The Location of a Closed Channel Gate in the GABAA Receptor ChannelThe Journal of general physiology, 2007
- Stoichiometry of a pore mutation that abolishes picrotoxin‐mediated antagonism of the GABAA receptorThe Journal of Physiology, 2006
- Molecular Determinants of Picrotoxin Inhibition of 5-Hydroxytryptamine Type 3 ReceptorsThe Journal of pharmacology and experimental therapeutics, 2005
- Identification of a Novel Residue within the Second Transmembrane Domain That Confers Use-facilitated Block by Picrotoxin in Glycine α1 ReceptorsPublished by Elsevier BV ,2002
- A single β subunit M2 domain residue controls the picrotoxin sensitivity of αβ heteromeric glycine receptor chloride channelsJournal of Neurochemistry, 2001